期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
金属支架置入联合放、化疗治疗恶性食管狭窄的临床分析 被引量:7
1
作者 韩泳涛 彭林 +1 位作者 方强 李强 《癌症》 SCIE CAS CSCD 北大核心 2004年第6期682-684,共3页
背景与目的:伴有吞咽困难症状的食管癌患者置入自膨式食管金属支架(self-expandingesophagealmetalstents,SEMS)后,是否进行放疗或/和化疗等综合治疗,尚存在较大争议,目前缺乏系统的对比研究。本研究拟探讨SEMS联合放、化疗治疗恶性食... 背景与目的:伴有吞咽困难症状的食管癌患者置入自膨式食管金属支架(self-expandingesophagealmetalstents,SEMS)后,是否进行放疗或/和化疗等综合治疗,尚存在较大争议,目前缺乏系统的对比研究。本研究拟探讨SEMS联合放、化疗治疗恶性食管狭窄的价值。方法:将283例患者分为单纯置入SEMS组(n=91)和综合治疗组(n=192),对两组的生存时间进行对比,采用Cox回归模型对生存时间的影响因素(包括治疗方式、是否有远处转移和淋巴结转移、有无瘘道形成以及病变部位)进行分析。结果:综合治疗组的生存时间明显长于单纯置入SEMS组,分别为(499.27±239.37)天和(312.81±192.77)天(P<0.0001)。影响生存时间的因素中,治疗方式的相对危险度最大。结论:安置SEMS后联合放疗或/和化疗对延长伴有吞咽困难症状的食管癌患者的生存时间更有效。 展开更多
关键词 食管肿瘤 恶性食管狭窄 金属支架 综合治疗 生存时间
在线阅读 下载PDF
Comparison of long-term clinical outcomes after percutaneous coronary intervention between in-stent restenosis and de novo chronic total occlusion
2
作者 CHAI Ren-jie ZHANG Bin +3 位作者 LIU Ning-ning ZHOU Yi LUO Bing-zheng HUANG Ze-han 《South China Journal of Cardiology》 CAS 2020年第1期6-11,共6页
Background The occurrence of in-stent restenosis(ISR)coronary chronic total occlusion(CTO)is presently increasing. However,there were few data related to the long-term clinical outcomes after percutaneous coronary int... Background The occurrence of in-stent restenosis(ISR)coronary chronic total occlusion(CTO)is presently increasing. However,there were few data related to the long-term clinical outcomes after percutaneous coronary intervention(PCI)between ISR CTO and de novo CTO. Methods A total of 435 CTO patients who had attempted PCI between Jan 2013 and November 2017 were screened for inclusion in this study. The Kaplan-Meier method was applied to estimate event-free survival and the log-rank test to compare long-term outcome. Cox regression analysis was used to identify associations between adverse events and risk factors. Results There were84 ISR CTO cases and 351 de novo CTO cases in this study. Successful revascularization was achieved similar between ISR CTO group and de novo CTO group(84.5% vs. 87.2%,P=0.592). The prevalence of MACE[17.9% vs. 9.1%;hazard ratio(HR):2.323;95% confidence interval(CI)1.233-4.37;P=0.004]and TLR(8.3% vs. 3.4%;HR:2.627;95% CI 1.05-6.53;P<0.016)were higher in the ISR CTO group,during the 2-year follow-up. Conclusions The procedural success rate of ISR CTO achieved was comparable to that of de novo CTO in the contemporary practice. But the long-term clinical outcome was significantly worse in term of major adverse cardiac events and target lesion revascularization. 展开更多
关键词 in⁃stent restenosis coronary chronic total occlusion PROGNOSIS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部